The Baker-Polito Administration has been selected as a partner in the nation’s first Biopharmaceutical Manufacturing Innovation Institute.
The $250 million Institute is a national public-private partnership, awarded through Manufacturing USA, a federally-authorized network of manufacturing innovation institutes. Federal matching funds for the institute will be provided by the US Department of Commerce’s National Institute of Standards and Technology.
The public-private partnership will develop and commercialize new advanced manufacturing technologies while training a skilled workforce.
Governor Charlie Baker says the new Institute will “ensure that our globally competitive life sciences cluster continues to deliver cutting-edge therapies, while providing quality manufacturing jobs to the citizens of Massachusetts.”
The Biopharmaceutical Manufacturing Innovation Institute is the sixth Manufacturing USA project secured under the Baker-Polito Administration. Massachusetts is anchoring the northeastern node for project, which will be known as the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a public-private partnership that seeks to solve challenges related to the production, testing, and regulation of new treatments.
Educational and research institutions participating include the Massachusetts Institute of Technology (MIT), Quincy College, UMass Lowell, UMass Medical School, and the Worcester Polytechnic Institute (WPI), along with a consortium of small, medium, and large biopharmaceutical industry partners from across the supply chain.
The Commonwealth is supporting NIIMBL’s collaborative research and development, and workforce training efforts, through a five-year, $20 million commitment from the Massachusetts Life Sciences Center (MLSC). The Commonwealth’s matching contribution leverages $70 million in federal funds, awarded to the national project, and additional matching funds from private sector participants.
Lieutenant Governor Karyn Polito says the partnership “will create new capacity to manufacture modern biopharmaceutical therapies in Massachusetts, and continue to broaden the reach of the life sciences cluster throughout the Commonwealth.”
Travis McCready, President and CEO of the Massachusetts Life Sciences Center, said the Institute “will build connections between our biomanufacturing innovators in industry and academia, and will connect the innovation going on in manufacturing with the innovation going on in the lab.”
The project will also train an advanced manufacturing workforce, capable of working in new biopharmaceutical manufacturing technologies.
Manufacturing USA, formerly known as the National Network for Manufacturing Institutes, is a network of competitively awarded public-private innovation institutes. Manufacturing USA seeks to spur research into cutting-edge technologies that can be applied to advanced manufacturing processes. Bidders frequently form teams of universities across different states, with regional nodes supporting the lead bidder. The federal awards are leveraged several times over through a series of state and industry matches.
Massachusetts is convening a national effort to develop revolutionary fibers and textiles, and the state is a participant in regional manufacturing innovation institute nodes in photonics, flexible hybrid electronics, smart manufacturing, and rapid process intensification.